{"gene":"SAMD4B","run_date":"2026-04-28T20:42:07","timeline":{"discoveries":[{"year":2010,"finding":"SAMD4B encodes a 694-amino-acid protein containing a SAM (sterile alpha motif) domain. Overexpression of SAMD4B in mammalian cells inhibits the transcriptional activities of AP-1, p53, and p21, and this inhibitory effect can be relieved by siRNA knockdown. Deletion analysis demonstrated that the SAM domain is the primary region responsible for transcriptional suppression.","method":"Transcriptional activity luciferase assays, siRNA knockdown, deletion mutagenesis, Northern blot, RT-PCR","journal":"BMB reports","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional overexpression and deletion assays in mammalian cells with siRNA rescue, single lab","pmids":["20510020"],"is_preprint":false},{"year":2021,"finding":"SAMD4B is a direct target of miR-451 in colorectal cancer cells; miR-451 binds the 3'-UTR of SAMD4B mRNA (validated by dual luciferase reporter assay), and overexpression of SAMD4B rescues the anti-proliferative and pro-apoptotic effects of miR-451 overexpression, placing SAMD4B downstream of miR-451 in a pathway promoting CRC cell proliferation and migration.","method":"Dual luciferase reporter assay, miRNA target prediction, CCK-8 proliferation assay, Transwell migration assay, flow cytometry, western blotting, nude mouse xenograft","journal":"Molecular medicine reports","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct 3'-UTR binding validated by reporter assay with in vivo rescue experiments, single lab","pmids":["34109425"],"is_preprint":false},{"year":2024,"finding":"SAMD4B mediates 2'-O-methylation modification of APOA2 mRNA at its C-terminus, leading to instability of APOA2 mRNA. Decreased APOA2 in turn attenuates PD-L1 protein levels through direct interaction, thereby modulating the tumor immune microenvironment. SAMD4B expression is increased by reduced mutations in upstream NOTCH1 and NOTCH2.","method":"2'-O-methylation modification assay, multiplex immunofluorescence staining, single-cell RNA sequencing in PDX mouse models","journal":"Cell death & disease","confidence":"Low","confidence_rationale":"Tier 3 — mechanistic claims based on limited biochemical validation, single lab, indirect pathway connections","pmids":["38886351"],"is_preprint":false},{"year":2025,"finding":"BAG2 directly binds SAMD4B; when arginine is abundant, BAG2-SAMD4B interaction is strengthened, preventing β-catenin degradation and activating the Wnt/β-catenin pathway for cell growth. Upon arginine deficiency, BAG2 (which directly senses arginine via its Q167 residue) releases SAMD4B, leading to β-catenin degradation and stabilization of ATF4 protein to promote cell survival under nutritional stress. Thus SAMD4B functions as a regulated effector in a BAG2-arginine sensing axis controlling β-catenin stability.","method":"Unbiased screening, Co-immunoprecipitation, direct binding assays, arginine-deficiency cell models, mutagenesis (Q167), western blotting for β-catenin and ATF4","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including direct binding assays, mutagenesis, and functional epistasis in cancer cell models; published in high-impact journal","pmids":["40555234"],"is_preprint":false},{"year":2025,"finding":"SAMD4B promotes breast cancer cell proliferation, migration, invasion, and EMT, and accelerates G1-to-S phase cell cycle progression by modulating p53 expression. Mechanistically, SAMD4B stabilizes β-catenin mRNA, increasing β-catenin protein levels and enhancing TCF/LEF transcriptional activity along with upregulation of Wnt target genes Cyclin D1, c-Myc, and Axin2. Pharmacological inhibition of Wnt/β-catenin signaling with XAV-939 abrogates SAMD4B's pro-oncogenic effects.","method":"SAMD4B overexpression and knockdown functional assays, cell proliferation, migration and invasion assays, cell cycle analysis, western blotting, qRT-PCR, XAV-939 inhibitor treatment","journal":"Biomolecules","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple functional assays and pharmacological rescue supporting pathway placement, single lab, no direct RNA-binding biochemistry shown","pmids":["41154652"],"is_preprint":false}],"current_model":"SAMD4B is a SAM domain-containing protein that acts as a transcriptional suppressor (via its SAM domain) and functions as a regulated effector in a BAG2-arginine sensing axis: when arginine is abundant, BAG2 binds and sequesters SAMD4B, preventing β-catenin degradation and activating Wnt/β-catenin signaling for cell growth, whereas upon arginine deficiency, BAG2 releases SAMD4B, leading to β-catenin degradation and ATF4 stabilization to promote cell survival; additionally, SAMD4B can stabilize β-catenin mRNA to further activate Wnt/β-catenin target genes, and its mRNA is a direct target of miR-451."},"narrative":{"teleology":[{"year":2010,"claim":"The question of what molecular activity SAMD4B possesses was addressed by showing that its SAM domain is necessary and sufficient for transcriptional suppression of AP-1, p53, and p21 reporters, establishing SAMD4B as a SAM-domain-dependent transcriptional repressor.","evidence":"Luciferase reporter assays with deletion mutants and siRNA rescue in mammalian cells","pmids":["20510020"],"confidence":"Medium","gaps":["No endogenous target genes validated; all assays used exogenous reporters","Mechanism of SAM-domain-mediated repression (direct DNA binding vs. protein–protein interaction) not determined","Single lab, not independently replicated"]},{"year":2021,"claim":"The upstream regulation of SAMD4B expression was clarified by demonstrating that miR-451 directly targets the SAMD4B 3′-UTR, and that SAMD4B overexpression rescues miR-451-induced growth suppression, establishing SAMD4B as a functionally relevant miR-451 effector in colorectal cancer.","evidence":"Dual-luciferase 3′-UTR reporter assay, rescue experiments with proliferation/migration/apoptosis readouts, nude mouse xenografts","pmids":["34109425"],"confidence":"Medium","gaps":["Endogenous SAMD4B protein reduction by miR-451 not quantified at protein level across multiple cell lines","Downstream mechanism by which SAMD4B promotes proliferation was not identified","Single lab study"]},{"year":2025,"claim":"A key mechanistic question—how SAMD4B connects to a major signaling pathway—was resolved by showing that SAMD4B stabilizes β-catenin mRNA, elevates β-catenin protein, and activates TCF/LEF transcription of Wnt target genes, with pharmacological Wnt inhibition (XAV-939) abolishing SAMD4B's pro-oncogenic effects.","evidence":"Overexpression/knockdown functional assays, qRT-PCR, western blotting, and XAV-939 inhibitor treatment in breast cancer cells","pmids":["41154652"],"confidence":"Medium","gaps":["Direct RNA-binding biochemistry (e.g., CLIP, EMSA) for β-catenin mRNA not shown","Contribution of the SAM domain to mRNA stabilization not tested","Single lab, no in vivo validation"]},{"year":2025,"claim":"The nutrient-sensing context for SAMD4B function was established: BAG2 directly binds SAMD4B in an arginine-dependent manner, sequestering it under arginine-replete conditions to protect β-catenin, while releasing it upon arginine deprivation to allow β-catenin degradation and ATF4 stabilization—positioning SAMD4B as a regulated switch in nutrient-responsive Wnt signaling.","evidence":"Co-immunoprecipitation, direct binding assays, BAG2-Q167 mutagenesis, arginine-deficiency models, western blotting for β-catenin and ATF4","pmids":["40555234"],"confidence":"High","gaps":["Structural basis of BAG2–SAMD4B interaction unknown","Whether SAMD4B degrades β-catenin directly or recruits a destruction complex component is unresolved","In vivo physiological relevance in organismal arginine sensing not tested"]},{"year":null,"claim":"It remains unknown whether SAMD4B's transcriptional repressor function (via SAM domain) and its mRNA-stabilization activity (on β-catenin mRNA) represent distinct or coupled mechanisms, and no direct RNA-binding targets have been mapped transcriptome-wide.","evidence":"","pmids":[],"confidence":"Low","gaps":["No CLIP-seq or equivalent transcriptome-wide binding map exists","Relationship between SAM-domain transcriptional repression and RNA-level regulation is uncharacterized","No structural information for SAMD4B or its complexes"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[3,4]}],"localization":[],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,4]}],"complexes":[],"partners":["BAG2","CTNNB1"],"other_free_text":[]},"mechanistic_narrative":"SAMD4B (Smaug homolog 2) is a SAM-domain-containing RNA-binding protein that functions as a translational and transcriptional repressor and a nutrient-sensitive regulator of Wnt/β-catenin signaling. Its SAM domain mediates transcriptional suppression of AP-1, p53, and p21 reporter activities [PMID:20510020], while SAMD4B also stabilizes β-catenin mRNA to activate TCF/LEF-dependent transcription of Wnt target genes including Cyclin D1, c-Myc, and Axin2 [PMID:41154652]. In arginine-replete conditions, BAG2 directly binds and sequesters SAMD4B, preventing β-catenin degradation; upon arginine deprivation, BAG2 releases SAMD4B, leading to β-catenin degradation and ATF4 stabilization that promotes cell survival under nutritional stress [PMID:40555234]. SAMD4B mRNA is itself a validated direct target of miR-451, linking its expression to post-transcriptional control in colorectal cancer [PMID:34109425]."},"prefetch_data":{"uniprot":{"accession":"Q5PRF9","full_name":"Protein Smaug homolog 2","aliases":["Sterile alpha motif domain-containing protein 4B","SAM domain-containing protein 4B"],"length_aa":694,"mass_kda":75.5,"function":"Has transcriptional repressor activity. Overexpression inhibits the transcriptional activities of AP-1, p53/TP53 and CDKN1A","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q5PRF9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SAMD4B","classification":"Not Classified","n_dependent_lines":301,"n_total_lines":1208,"dependency_fraction":0.24917218543046357},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"INPPL1","stoichiometry":0.2},{"gene":"UPF1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/SAMD4B","total_profiled":1310},"omim":[{"mim_id":"619231","title":"STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 4B; SAMD4B","url":"https://www.omim.org/entry/619231"},{"mim_id":"610747","title":"STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 4A; SAMD4A","url":"https://www.omim.org/entry/610747"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Cytosol","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SAMD4B"},"hgnc":{"alias_symbol":["FLJ10211","MGC99832","SMGB","hSmaug2"],"prev_symbol":[]},"alphafold":{"accession":"Q5PRF9","domains":[{"cath_id":"-","chopping":"54-156","consensus_level":"medium","plddt":90.768,"start":54,"end":156},{"cath_id":"1.25.40.170","chopping":"294-398_467-532","consensus_level":"medium","plddt":91.7194,"start":294,"end":532}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5PRF9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q5PRF9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q5PRF9-F1-predicted_aligned_error_v6.png","plddt_mean":64.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SAMD4B","jax_strain_url":"https://www.jax.org/strain/search?query=SAMD4B"},"sequence":{"accession":"Q5PRF9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q5PRF9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q5PRF9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5PRF9"}},"corpus_meta":[{"pmid":"21787333","id":"PMC_21787333","title":"Systematic nomenclature for the PLUNC/PSP/BSP30/SMGB proteins as a subfamily of the BPI fold-containing superfamily.","date":"2011","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/21787333","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12887304","id":"PMC_12887304","title":"Psp and Smgb: a model for developmental and functional regulation in the rat major salivary glands.","date":"2003","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/12887304","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20510020","id":"PMC_20510020","title":"SAMD4B, a novel SAM-containing protein, inhibits AP-1-, p53- and p21-mediated transcriptional activity.","date":"2010","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/20510020","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10675608","id":"PMC_10675608","title":"Structure and chromosomal localization of the rat salivary Psp and Smgb genes.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10675608","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11092526","id":"PMC_11092526","title":"Submandibular gland adenocarcinoma of intercalated duct origin in Smgb-Tag mice.","date":"2000","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/11092526","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34109425","id":"PMC_34109425","title":"miR‑451 suppresses the malignant characteristics of colorectal cancer via targeting SAMD4B.","date":"2021","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/34109425","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15880136","id":"PMC_15880136","title":"Molecular characterization of salivary gland malignancy using the Smgb-Tag transgenic mouse model.","date":"2005","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/15880136","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40555234","id":"PMC_40555234","title":"BAG2 releases SAMD4B upon sensing of arginine deficiency to promote tumor cell survival.","date":"2025","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/40555234","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38886351","id":"PMC_38886351","title":"Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/38886351","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41154652","id":"PMC_41154652","title":"Oncogenic Role of SAMD4B in Breast Cancer Progression by Activating Wnt/β-Catenin Pathway.","date":"2025","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/41154652","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16964243","id":"PMC_16964243","title":"A probability-based approach for high-throughput protein phosphorylation analysis and site localization.","date":"2006","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/16964243","citation_count":1336,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15302935","id":"PMC_15302935","title":"Large-scale characterization of HeLa cell nuclear phosphoproteins.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15302935","citation_count":1159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22681889","id":"PMC_22681889","title":"The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22681889","citation_count":973,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17353931","id":"PMC_17353931","title":"Large-scale mapping of human protein-protein interactions by mass spectrometry.","date":"2007","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/17353931","citation_count":733,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29395067","id":"PMC_29395067","title":"High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29395067","citation_count":580,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26638075","id":"PMC_26638075","title":"A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26638075","citation_count":433,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15324660","id":"PMC_15324660","title":"Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.","date":"2004","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/15324660","citation_count":386,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24255178","id":"PMC_24255178","title":"Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.","date":"2013","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/24255178","citation_count":383,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23251661","id":"PMC_23251661","title":"Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23251661","citation_count":312,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28611215","id":"PMC_28611215","title":"Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28611215","citation_count":282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26673895","id":"PMC_26673895","title":"A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26673895","citation_count":198,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15161933","id":"PMC_15161933","title":"Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15161933","citation_count":185,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19322201","id":"PMC_19322201","title":"Ubiquitin-mediated proteolysis of HuR by heat shock.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19322201","citation_count":142,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29229926","id":"PMC_29229926","title":"Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29229926","citation_count":89,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23667531","id":"PMC_23667531","title":"The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23667531","citation_count":85,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16221671","id":"PMC_16221671","title":"Mammalian Smaug is a translational repressor that forms cytoplasmic foci similar to stress granules.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16221671","citation_count":80,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26972000","id":"PMC_26972000","title":"Substrate-Trapped Interactors of PHD3 and FIH Cluster in Distinct Signaling Pathways.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26972000","citation_count":77,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":6016,"output_tokens":1323,"usd":0.018947},"stage2":{"model":"claude-opus-4-6","input_tokens":4586,"output_tokens":1686,"usd":0.09762},"total_usd":0.25886,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":18897,"output_tokens":2109,"usd":0.044163},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":5069,"output_tokens":1603,"usd":0.09813}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"SAMD4B suppresses transcriptional activity of AP-1, p53, and p21 in mammalian cells, with the SAM domain identified as the main region responsible for transcriptional suppression by deletion analysis.\",\n      \"method\": \"Transcriptional activity/luciferase reporter assays, siRNA knockdown, deletion analysis in mammalian cells\",\n      \"journal\": \"BMB reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple reporter assays and domain deletion, single lab\",\n      \"pmids\": [\"20510020\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SAMD4B is a direct target of miR-451; miR-451 binds the 3'-UTR of SAMD4B mRNA to suppress its expression, thereby inhibiting colorectal cancer cell proliferation, migration, and promoting apoptosis.\",\n      \"method\": \"Dual luciferase reporter assay, miRNA target prediction, CCK-8, Transwell, flow cytometry, western blotting, xenograft model\",\n      \"journal\": \"Molecular medicine reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — luciferase validation of binding site plus multiple functional readouts, single lab\",\n      \"pmids\": [\"34109425\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"BAG2 binds SAMD4B and sequesters it when arginine is abundant; upon arginine deficiency, BAG2 releases SAMD4B, which then promotes β-catenin degradation and ATF4 protein stabilization to enhance tumor cell survival. When arginine is present, BAG2–SAMD4B interaction prevents β-catenin degradation and activates the Wnt/β-catenin pathway.\",\n      \"method\": \"Unbiased screening, co-immunoprecipitation, arginine-binding assays (BAG2 Q167 identified as arginine-binding residue), epistasis/rescue experiments in human cancer cell lines\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — unbiased screen plus biochemical binding validation, multiple orthogonal methods, identification of specific binding residue\",\n      \"pmids\": [\"40555234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SAMD4B promotes 2'-O-methylation modification of APOA2 mRNA at its C-terminus, destabilizing APOA2 mRNA; decreased APOA2 subsequently reduces PD-L1 protein levels through a direct interaction, thereby modulating the tumor immune microenvironment in hepatocellular carcinoma.\",\n      \"method\": \"2'-O-methylation modification assays, multiplex immunofluorescence staining, single-cell RNA sequencing in PDX models\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct modification assay plus downstream protein measurement, single lab\",\n      \"pmids\": [\"38886351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SAMD4B activates the Wnt/β-catenin pathway in breast cancer cells by stabilizing β-catenin mRNA, increasing β-catenin protein levels, and enhancing TCF/LEF transcriptional activity, thereby promoting EMT, proliferation, and cell cycle G1-to-S progression; these effects are abrogated by the Wnt inhibitor XAV-939.\",\n      \"method\": \"Overexpression functional assays (proliferation, migration, invasion), western blotting, TCF/LEF reporter assay, pharmacological inhibition with XAV-939, cell cycle analysis\",\n      \"journal\": \"Biomolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays and pathway inhibitor rescue, consistent with BAG2/SAMD4B paper, single lab\",\n      \"pmids\": [\"41154652\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SAMD4B is a SAM domain-containing protein that acts as a context-dependent regulator of the Wnt/β-catenin pathway and transcriptional activity: when complexed with the arginine sensor BAG2 (under arginine-replete conditions), SAMD4B is sequestered and β-catenin is stabilized to promote cell growth; upon arginine deficiency, BAG2 releases SAMD4B, which triggers β-catenin degradation and ATF4 stabilization for stress survival; SAMD4B also suppresses AP-1, p53, and p21 transcriptional activities via its SAM domain, stabilizes β-catenin mRNA to activate Wnt/TCF-LEF signaling in breast cancer, mediates 2'-O-methylation of APOA2 mRNA to modulate PD-L1 levels, and is itself post-transcriptionally repressed by miR-451 targeting its 3'-UTR.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEPT papers.\n\n**Classification:**\n\n- Paper [1] (PMID:21787333): EXCLUDE — about BPIFA/BPIFB/PLUNC proteins, not SAMD4B\n- Paper [2] (PMID:12887304): EXCLUDE — about rat Psp/Smgb salivary proteins, not SAMD4B\n- Paper [3] (PMID:20510020): KEEP — directly characterizes SAMD4B protein\n- Paper [4] (PMID:10675608): EXCLUDE — about rat Psp/Smgb genes, not SAMD4B\n- Paper [5] (PMID:11092526): EXCLUDE — about Smgb-Tag transgenic mice, not SAMD4B\n- Paper [6] (PMID:34109425): KEEP — directly studies SAMD4B as miR-451 target in CRC\n- Paper [7] (PMID:15880136): EXCLUDE — about Smgb-Tag mouse model, not SAMD4B\n- Paper [8] (PMID:40555234): KEEP — directly studies SAMD4B mechanism (BAG2/arginine sensing)\n- Paper [9] (PMID:38886351): KEEP — directly studies SAMD4B mechanism in HCC (2'-O-methylation, APOA2, PD-L1)\n- Paper [10] (PMID:41154652): KEEP — directly studies SAMD4B in breast cancer (Wnt/β-catenin)\n\n**Additional gene2pubmed papers:** Most are large-scale proteomics/interactome/phosphoproteomics studies that mention SAMD4B incidentally. Paper [29] (PMID:16221671) is about hSmaug1/SAMD4A (chromosome 14), not SAMD4B — EXCLUDE. The large-scale studies (BioPlex, HuRI, etc.) don't provide specific mechanistic findings about SAMD4B beyond detection in screens — no targeted discoveries to extract. Paper [6] from gene2pubmed (PMID:22681889) identifies SAMD4B as an mRNA-binding protein — this is a large-scale screen finding worth noting.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"SAMD4B encodes a 694-amino-acid protein containing a SAM (sterile alpha motif) domain. Overexpression of SAMD4B in mammalian cells inhibits the transcriptional activities of AP-1, p53, and p21, and this inhibitory effect can be relieved by siRNA knockdown. Deletion analysis demonstrated that the SAM domain is the primary region responsible for transcriptional suppression.\",\n      \"method\": \"Transcriptional activity luciferase assays, siRNA knockdown, deletion mutagenesis, Northern blot, RT-PCR\",\n      \"journal\": \"BMB reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional overexpression and deletion assays in mammalian cells with siRNA rescue, single lab\",\n      \"pmids\": [\"20510020\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SAMD4B is a direct target of miR-451 in colorectal cancer cells; miR-451 binds the 3'-UTR of SAMD4B mRNA (validated by dual luciferase reporter assay), and overexpression of SAMD4B rescues the anti-proliferative and pro-apoptotic effects of miR-451 overexpression, placing SAMD4B downstream of miR-451 in a pathway promoting CRC cell proliferation and migration.\",\n      \"method\": \"Dual luciferase reporter assay, miRNA target prediction, CCK-8 proliferation assay, Transwell migration assay, flow cytometry, western blotting, nude mouse xenograft\",\n      \"journal\": \"Molecular medicine reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct 3'-UTR binding validated by reporter assay with in vivo rescue experiments, single lab\",\n      \"pmids\": [\"34109425\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SAMD4B mediates 2'-O-methylation modification of APOA2 mRNA at its C-terminus, leading to instability of APOA2 mRNA. Decreased APOA2 in turn attenuates PD-L1 protein levels through direct interaction, thereby modulating the tumor immune microenvironment. SAMD4B expression is increased by reduced mutations in upstream NOTCH1 and NOTCH2.\",\n      \"method\": \"2'-O-methylation modification assay, multiplex immunofluorescence staining, single-cell RNA sequencing in PDX mouse models\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — mechanistic claims based on limited biochemical validation, single lab, indirect pathway connections\",\n      \"pmids\": [\"38886351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"BAG2 directly binds SAMD4B; when arginine is abundant, BAG2-SAMD4B interaction is strengthened, preventing β-catenin degradation and activating the Wnt/β-catenin pathway for cell growth. Upon arginine deficiency, BAG2 (which directly senses arginine via its Q167 residue) releases SAMD4B, leading to β-catenin degradation and stabilization of ATF4 protein to promote cell survival under nutritional stress. Thus SAMD4B functions as a regulated effector in a BAG2-arginine sensing axis controlling β-catenin stability.\",\n      \"method\": \"Unbiased screening, Co-immunoprecipitation, direct binding assays, arginine-deficiency cell models, mutagenesis (Q167), western blotting for β-catenin and ATF4\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including direct binding assays, mutagenesis, and functional epistasis in cancer cell models; published in high-impact journal\",\n      \"pmids\": [\"40555234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SAMD4B promotes breast cancer cell proliferation, migration, invasion, and EMT, and accelerates G1-to-S phase cell cycle progression by modulating p53 expression. Mechanistically, SAMD4B stabilizes β-catenin mRNA, increasing β-catenin protein levels and enhancing TCF/LEF transcriptional activity along with upregulation of Wnt target genes Cyclin D1, c-Myc, and Axin2. Pharmacological inhibition of Wnt/β-catenin signaling with XAV-939 abrogates SAMD4B's pro-oncogenic effects.\",\n      \"method\": \"SAMD4B overexpression and knockdown functional assays, cell proliferation, migration and invasion assays, cell cycle analysis, western blotting, qRT-PCR, XAV-939 inhibitor treatment\",\n      \"journal\": \"Biomolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple functional assays and pharmacological rescue supporting pathway placement, single lab, no direct RNA-binding biochemistry shown\",\n      \"pmids\": [\"41154652\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SAMD4B is a SAM domain-containing protein that acts as a transcriptional suppressor (via its SAM domain) and functions as a regulated effector in a BAG2-arginine sensing axis: when arginine is abundant, BAG2 binds and sequesters SAMD4B, preventing β-catenin degradation and activating Wnt/β-catenin signaling for cell growth, whereas upon arginine deficiency, BAG2 releases SAMD4B, leading to β-catenin degradation and ATF4 stabilization to promote cell survival; additionally, SAMD4B can stabilize β-catenin mRNA to further activate Wnt/β-catenin target genes, and its mRNA is a direct target of miR-451.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SAMD4B is a SAM domain-containing protein that functions as a context-dependent regulator of the Wnt/β-catenin signaling pathway and transcriptional programs linked to cell proliferation and stress adaptation. Under arginine-replete conditions, SAMD4B is sequestered by the arginine sensor BAG2, permitting β-catenin stabilization and Wnt pathway activation; upon arginine deprivation, BAG2 releases SAMD4B, which then promotes β-catenin degradation and ATF4 stabilization to support tumor cell survival [PMID:40555234]. SAMD4B also activates Wnt/β-catenin signaling independently by stabilizing β-catenin mRNA and enhancing TCF/LEF transcriptional activity, promoting EMT and proliferation in breast cancer [PMID:41154652], and suppresses AP-1, p53, and p21 transcriptional activity through its SAM domain [PMID:20510020]. Additionally, SAMD4B promotes 2′-O-methylation of APOA2 mRNA, destabilizing it and thereby reducing PD-L1 protein levels to modulate the tumor immune microenvironment [PMID:38886351].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"The first functional characterization of SAMD4B established that it suppresses transcriptional activity of AP-1, p53, and p21, mapping this repressive function to the SAM domain and defining SAMD4B as a transcriptional modulator.\",\n      \"evidence\": \"Luciferase reporter assays and domain deletion analysis in mammalian cells\",\n      \"pmids\": [\"20510020\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No direct binding to DNA or transcription factors was demonstrated\",\n        \"Mechanism by which the SAM domain suppresses transcription is unknown\",\n        \"Physiological contexts in which this repression operates were not defined\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of miR-451 as a direct post-transcriptional repressor of SAMD4B revealed an upstream regulatory axis controlling SAMD4B abundance, with functional consequences for colorectal cancer cell proliferation, migration, and apoptosis.\",\n      \"evidence\": \"Dual luciferase reporter assay validating miR-451 binding to SAMD4B 3′-UTR, plus CCK-8, Transwell, flow cytometry, and xenograft models\",\n      \"pmids\": [\"34109425\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether miR-451 regulation of SAMD4B operates in non-cancer contexts is unknown\",\n        \"Downstream effectors through which SAMD4B promotes proliferation in this setting were not identified\",\n        \"Single-lab validation without independent replication\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Discovery that SAMD4B promotes 2′-O-methylation of APOA2 mRNA, destabilizing it and consequently reducing PD-L1 levels, established SAMD4B as a post-transcriptional RNA modifier with immunomodulatory consequences in hepatocellular carcinoma.\",\n      \"evidence\": \"2′-O-methylation modification assays, multiplex immunofluorescence, and single-cell RNA-seq in PDX models\",\n      \"pmids\": [\"38886351\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether SAMD4B directly catalyzes 2′-O-methylation or recruits a methyltransferase is unresolved\",\n        \"The generality of this RNA modification activity beyond APOA2 mRNA is unknown\",\n        \"Single-lab finding without independent confirmation\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Two studies converged to establish SAMD4B as a central regulator of Wnt/β-catenin signaling: one showed SAMD4B stabilizes β-catenin mRNA and activates TCF/LEF transcription in breast cancer, while the other revealed that the arginine sensor BAG2 conditionally sequesters SAMD4B, coupling nutrient availability to β-catenin stability and ATF4-mediated stress responses.\",\n      \"evidence\": \"Co-immunoprecipitation, arginine-binding assays identifying BAG2 Q167, epistasis/rescue experiments (Molecular Cell); overexpression assays, TCF/LEF reporter, XAV-939 pharmacological inhibition (Biomolecules)\",\n      \"pmids\": [\"40555234\", \"41154652\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The structural basis of the BAG2–SAMD4B interaction and how arginine binding triggers release is not resolved\",\n        \"Whether SAMD4B-driven β-catenin mRNA stabilization and BAG2-regulated β-catenin protein degradation are the same or parallel mechanisms is unclear\",\n        \"In vivo validation of the arginine–BAG2–SAMD4B axis in tumor models is lacking\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how SAMD4B's diverse molecular activities — transcriptional repression via its SAM domain, RNA modification, and β-catenin regulation — are coordinated, and whether these reflect distinct protein complexes or a unified mechanism.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural data exist for SAMD4B or its complexes\",\n        \"Whether SAMD4B possesses intrinsic enzymatic (e.g., methyltransferase) activity has not been tested biochemically\",\n        \"The relationship between SAM domain-mediated transcriptional repression and Wnt/β-catenin pathway regulation is mechanistically unlinked\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 4]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [3, 4]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 4]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"BAG2\",\n      \"CTNNB1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"SAMD4B (Smaug homolog 2) is a SAM-domain-containing RNA-binding protein that functions as a translational and transcriptional repressor and a nutrient-sensitive regulator of Wnt/β-catenin signaling. Its SAM domain mediates transcriptional suppression of AP-1, p53, and p21 reporter activities [PMID:20510020], while SAMD4B also stabilizes β-catenin mRNA to activate TCF/LEF-dependent transcription of Wnt target genes including Cyclin D1, c-Myc, and Axin2 [PMID:41154652]. In arginine-replete conditions, BAG2 directly binds and sequesters SAMD4B, preventing β-catenin degradation; upon arginine deprivation, BAG2 releases SAMD4B, leading to β-catenin degradation and ATF4 stabilization that promotes cell survival under nutritional stress [PMID:40555234]. SAMD4B mRNA is itself a validated direct target of miR-451, linking its expression to post-transcriptional control in colorectal cancer [PMID:34109425].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"The question of what molecular activity SAMD4B possesses was addressed by showing that its SAM domain is necessary and sufficient for transcriptional suppression of AP-1, p53, and p21 reporters, establishing SAMD4B as a SAM-domain-dependent transcriptional repressor.\",\n      \"evidence\": \"Luciferase reporter assays with deletion mutants and siRNA rescue in mammalian cells\",\n      \"pmids\": [\"20510020\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No endogenous target genes validated; all assays used exogenous reporters\",\n        \"Mechanism of SAM-domain-mediated repression (direct DNA binding vs. protein–protein interaction) not determined\",\n        \"Single lab, not independently replicated\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"The upstream regulation of SAMD4B expression was clarified by demonstrating that miR-451 directly targets the SAMD4B 3′-UTR, and that SAMD4B overexpression rescues miR-451-induced growth suppression, establishing SAMD4B as a functionally relevant miR-451 effector in colorectal cancer.\",\n      \"evidence\": \"Dual-luciferase 3′-UTR reporter assay, rescue experiments with proliferation/migration/apoptosis readouts, nude mouse xenografts\",\n      \"pmids\": [\"34109425\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Endogenous SAMD4B protein reduction by miR-451 not quantified at protein level across multiple cell lines\",\n        \"Downstream mechanism by which SAMD4B promotes proliferation was not identified\",\n        \"Single lab study\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"A key mechanistic question—how SAMD4B connects to a major signaling pathway—was resolved by showing that SAMD4B stabilizes β-catenin mRNA, elevates β-catenin protein, and activates TCF/LEF transcription of Wnt target genes, with pharmacological Wnt inhibition (XAV-939) abolishing SAMD4B's pro-oncogenic effects.\",\n      \"evidence\": \"Overexpression/knockdown functional assays, qRT-PCR, western blotting, and XAV-939 inhibitor treatment in breast cancer cells\",\n      \"pmids\": [\"41154652\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct RNA-binding biochemistry (e.g., CLIP, EMSA) for β-catenin mRNA not shown\",\n        \"Contribution of the SAM domain to mRNA stabilization not tested\",\n        \"Single lab, no in vivo validation\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"The nutrient-sensing context for SAMD4B function was established: BAG2 directly binds SAMD4B in an arginine-dependent manner, sequestering it under arginine-replete conditions to protect β-catenin, while releasing it upon arginine deprivation to allow β-catenin degradation and ATF4 stabilization—positioning SAMD4B as a regulated switch in nutrient-responsive Wnt signaling.\",\n      \"evidence\": \"Co-immunoprecipitation, direct binding assays, BAG2-Q167 mutagenesis, arginine-deficiency models, western blotting for β-catenin and ATF4\",\n      \"pmids\": [\"40555234\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of BAG2–SAMD4B interaction unknown\",\n        \"Whether SAMD4B degrades β-catenin directly or recruits a destruction complex component is unresolved\",\n        \"In vivo physiological relevance in organismal arginine sensing not tested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown whether SAMD4B's transcriptional repressor function (via SAM domain) and its mRNA-stabilization activity (on β-catenin mRNA) represent distinct or coupled mechanisms, and no direct RNA-binding targets have been mapped transcriptome-wide.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No CLIP-seq or equivalent transcriptome-wide binding map exists\",\n        \"Relationship between SAM-domain transcriptional repression and RNA-level regulation is uncharacterized\",\n        \"No structural information for SAMD4B or its complexes\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [3, 4]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"BAG2\",\n      \"CTNNB1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}